UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

ANNALS OF ONCOLOGY, 2020, Vol.31 (Suppl. 2), p.S49

2020

Volltextzugriff (PDF)

Breast cancer in young women: poor survival despite intensive treatment

PloS one, 2009-11, Vol.4 (11), p.e7695-e7695

2009

Volltextzugriff (PDF)

HM31 Breast cancer in young women – age a risk factor only in those not given chemotherapy

Breast (Edinburgh), 2014-11, Vol.23, p.S12-S12

2014

Volltextzugriff (PDF)

Long-term outcome in young women with breast cancer: a population-based study

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.131-143

2016

Volltextzugriff (PDF)

115P Factors associated with mastectomy in women with small residual tumour after neoadjuvant chemotherapy for breast cancer

Annals of oncology, 2020-05, Vol.31, p.S54-S54

2020

Volltextzugriff (PDF)

CN60 OptiBra study: An RCT, optimal postoperative bra support after breast cancer surgery

Annals of oncology, 2022-09, Vol.33, p.S1371

2022

Volltextzugriff (PDF)

Breast cancer in young women - age a risk factor only in those not given chemotherapy

BREAST, 2014, Vol.23 (S1), p.S12

2014

Volltextzugriff (PDF)

Magseed application for detecting recurrent lymph node metastasis in papillary thyroid cancer: A novel minimally invasive Approach

European journal of surgical oncology, 2024-11, Vol.50 (11), p.108624, Article 108624

2024

Volltextzugriff (PDF)

Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Clinical cancer research, 2023-02, Vol.29 (3), p.532-540

2023

Volltextzugriff (PDF)

Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1739-1748

2024

Volltextzugriff (PDF)

OptiBra study, a randomized controlled trial on optimal postoperative bra support after breast cancer surgery

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2023-04, Vol.63, p.102285-102285, Article 102285

2023

Volltextzugriff (PDF)

ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1789-1790

2024

Volltextzugriff (PDF)

The Natural History of Ductal Carcinoma In Situ of the Breast - An Overview

Chirurgia (Bucharest, Romania : 1990), 2021-12, Vol.116 (5 Suppl), p.S7-S14

2021

Volltextzugriff (PDF)

Breast cancer in young women and prognosis: How important are proliferation markers?

European journal of cancer (1990), 2017-10, Vol.84, p.278-289

2017

Volltextzugriff (PDF)

Combined assessment of metabolic response and tumor infiltrating lymphocytes as a predictor of outcomes following neoadjuvant therapy for HER2-positive breast cancer: Results from the randomized PREDIX HER2 trial

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16_suppl), p.593-593

2022

Volltextzugriff (PDF)

One-year follow-up of health-related quality of life in the Swedish PREDIX HER 2 trial, evaluating docetaxel, trastuzumab sc, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2 positive breast cancer

JOURNAL OF CLINICAL ONCOLOGY, 2020, Vol.38 (15_suppl), p.590-590

2020

Volltextzugriff (PDF)

Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer

JOURNAL OF CLINICAL ONCOLOGY, 2019, Vol.37 (15_suppl), p.583-583

2019

Volltextzugriff (PDF)

97O PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

Annals of oncology, 2020-05, Vol.31, p.S49-S49

2020

Volltextzugriff (PDF)

Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview

Chirurgia (Bucharest, Romania : 1990), 2021, Vol.116 (5 Suppl), p.S128-S135

2021

Volltextzugriff (PDF)

Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: Results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?

JOURNAL OF CLINICAL ONCOLOGY, 2019, Vol.37 (15_suppl), p.501-501

2019

Volltextzugriff (PDF)

Risk of Venous Thromboembolic Events After Surgery for Cancer

JAMA network open, 2024-02, Vol.7 (2), p.e2354352

2024

Volltextzugriff (PDF)

Factors associated with mastectomy in women with small residual tumour after neoadjuvant chemotherapy for breast cancer

ANNALS OF ONCOLOGY, 2020, Vol.31, p.S54

2020

Volltextzugriff (PDF)

OptiBra study: An RCT, optimal postoperative bra support after breast cancer surgery

ANNALS OF ONCOLOGY, 2022, Vol.33 (7), p.S1371

2022

Volltextzugriff (PDF)

Worse prognosis for young women with breast cancer

Läkartidningen, 2017-02, Vol.114

2017

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(137)
Animals
(121)
Female
(67)
Male
(61)
Biological And Medical Sciences
(59)
Medicin Och Hälsovetenskap
(56)
Humans
(51)
Genetics & Heredity
(41)
Fundamental And Applied Biological Sciences. Psychology
(40)
Rats
(28)
Swine
(28)
Dogs
(25)
Mice
(23)
Genetics
(20)
Medical Sciences
(20)
Agriculture
(19)
Agriculture, Dairy & Animal Science
(19)
Biochemistry & Molecular Biology
(18)
Genotype
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

Breast cancer in young women: poor survival despite intensive treatment

HM31 Breast cancer in young women – age a risk factor only in those not given chemotherapy

Long-term outcome in young women with breast cancer: a population-based study

115P Factors associated with mastectomy in women with small residual tumour after neoadjuvant chemotherapy for breast cancer

CN60 OptiBra study: An RCT, optimal postoperative bra support after breast cancer surgery

Breast cancer in young women - age a risk factor only in those not given chemotherapy

Magseed application for detecting recurrent lymph node metastasis in papillary thyroid cancer: A novel minimally invasive Approach

Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer

OptiBra study, a randomized controlled trial on optimal postoperative bra support after breast cancer surgery

ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?

The Natural History of Ductal Carcinoma In Situ of the Breast - An Overview

Breast cancer in young women and prognosis: How important are proliferation markers?

Combined assessment of metabolic response and tumor infiltrating lymphocytes as a predictor of outcomes following neoadjuvant therapy for HER2-positive breast cancer: Results from the randomized PREDIX HER2 trial

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial

One-year follow-up of health-related quality of life in the Swedish PREDIX HER 2 trial, evaluating docetaxel, trastuzumab sc, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2 positive breast cancer

Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer

97O PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels

Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview

Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: Results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?

Risk of Venous Thromboembolic Events After Surgery for Cancer

Factors associated with mastectomy in women with small residual tumour after neoadjuvant chemotherapy for breast cancer

OptiBra study: An RCT, optimal postoperative bra support after breast cancer surgery

Worse prognosis for young women with breast cancer

Suchergebnisse filtern